AI assistant
Glenmark Pharmaceuticals ltd — Call Transcript 2022
Jun 3, 2022
62608_rns_2022-06-03_29327c14-4420-46fa-a0ef-02b6faf60e8e.pdf
Call Transcript
Open in viewerOpens in your device viewer
==> picture [33 x 32] intentionally omitted <==
==> picture [148 x 45] intentionally omitted <==
June 03, 2022
To, To, Dy. General Manager The Manager – Listing, Department of Corporate Services, National Stock Exchange of India Ltd., BSE Ltd., Plot No. C/1, G Block, P. J. Towers, Dalal Street, Bandra Kurla Complex, Fort, Mumbai – 400 001 Bandra (E), Mumbai – 400 051
Ref: Scrip Code: 532296
Ref: Scrip Name: GLENMARK
Dear Sirs,
Sub: Transcript of the Earnings Call
Further to our letter dated 19th May, 2022 and pursuant to Regulation 30(6) read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, the transcript of the Earnings call held on Monday, May 30, 2022 for the quarter and year ended March 31, 2022 has been uploaded on the Company’s website at https://glenmarkpharma.com/gpl_pdfs/investors/reports_presentations/earning_concall/Ea rnings_Call_Transcript_Q4FY23.pdf
Request you to kindly take the same on record.
Thanking you.
Yours faithfully,
For Glenmark Pharmaceuticals Limited
HARISH VINAYAK Digitally signed by HARISH VINAYAK KUBER KUBER Date: 2022.06.03 17:16:10 +05'30'
Harish Kuber
Company Secretary & Compliance Officer
Tel: 4018 9999 / 4018 9879 Fax: 4018 9986 (Legal & Secretarial Dept.)
Glenmark Pharmaceuticals Ltd. Glenmark House, B D Sawant Marg, Andheri (E), Mumbai 400 099 T: 91 22 4018 9999 F: 91 22 4018 9988 CIN No: L24299MH1977PLC019982 W: www.glenmarkpharma.com Registered office: B/2, Mahalaxmi Chambers, 22 Bhulabhai Desai Road, Mumbai 400 026 E: [email protected]